Gilead Raday

Gilead Raday is the Chief Operating Officer & Head of R&D at RedHill Biopharma. Gilead previously served as interim CEO of Sepal Pharma, and as a director at TK Signal and Morria Biopharmaceuticals. He is a graduate of the University of Cambridge (M.Sc. in Bioscience Enterprise) and the Hebrew University of Jerusalem (M.Sc. Neurobiology, BSc Mathematics and Biology).

Posts by Gilead Raday

MedCity Influencers, BioPharma

There is an urgent need for oral Covid-19 therapeutics as variants escalate

There is an urgent need to support the development of diverse and differentiated, multi-mechanistic and potentially complementary therapies, that are effective against Covid-19, are unaffected by the threat of viral mutation and, more critically than ever, are easy to make, distribute and take by the patient.